← Back to Search

Noninvasive Brain Stimulation

iTBS for HIV/AIDS

N/A
Waitlist Available
Led By Gopalkumar Rakesh, MD
Research Sponsored by Gopalkumar Rakesh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and immediately after intervention, approximately 4 hours
Awards & highlights

Study Summary

This study is evaluating whether a brain stimulation technique can help people with HIV/AIDS quit smoking.

Eligible Conditions
  • HIV/AIDS
  • Smoking Cessation
  • Craving

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and immediately after intervention, approximately 4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and immediately after intervention, approximately 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Attentional Bias Sham Paraphernalia
Change in Attentional Bias Sham Smoking
Change in Attentional Bias iTBS (Intermittent Theta Burst Stimulation) Smoking
+1 more
Secondary outcome measures
Change in Tobacco Craving Questionnaire Short Form (TCQ-SF) Sham
Change in Tobacco Craving Questionnaire Short Form (TCQ-SF) iTBS
Other outcome measures
Resting State Functional Connectiivity

Trial Design

1Treatment groups
Experimental Treatment
Group I: People Living with HIV/AIDS Who SmokeExperimental Treatment2 Interventions
Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iTBS
2019
Completed Phase 3
~640
TMS
2021
Completed Phase 2
~2170

Find a Location

Who is running the clinical trial?

Gopalkumar RakeshLead Sponsor
3 Previous Clinical Trials
130 Total Patients Enrolled
Gopalkumar Rakesh, MDPrincipal Investigator - Assistant Professor, University of Kentucky
University of Kentucky
1 Previous Clinical Trials
6 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)
Gopalkumar Rakesh 2021. "TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04936594.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top